about
Membrane transport of camptothecin: facilitation by human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2)Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells.Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in CancerBreast Cancer-Derived Extracellular Vesicles: Characterization and Contribution to the Metastatic PhenotypeTwo-colour live-cell nanoscale imaging of intracellular targets.Characterization of anti-Toxoplasma activity of SDZ 215-918, a cyclosporin derivative lacking immunosuppressive and peptidyl-prolyl-isomerase-inhibiting activity: possible role of a P glycoprotein in Toxoplasma physiologyRegulation of human hepatic drug transporter activity and expression by diesel exhaust particle extractInfluence of intermittent hypoxia on myocardial and hepatic P-glycoprotein expression in a rodent modelTachycardia-induced heart failure does not alter myocardial P-glycoprotein expression.Petiveria alliacea extracts uses multiple mechanisms to inhibit growth of human and mouse tumoral cells.Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells.Photochemical internalization-mediated delivery of chemotherapeutic agents in human breast tumor cell lines.Studies toward the Development of Antiproliferative Neoclerodanes from Salvinorin A.High glucose decreases expression and activity of p-glycoprotein in cultured human retinal pigment epithelium possibly through iNOS induction.The Role of P-Glycoprotein in Transport of Danshensu across the Blood-Brain Barrier.Imaging recognition of multidrug resistance in human breast tumors using 99mTc-labeled monocationic agents and a high-resolution stationary SPECT system.Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lambliaThe effects of multifunctional MiR-122-loaded graphene-gold composites on drug-resistant liver cancer.A highly tumor-targeted nanoparticle of podophyllotoxin penetrated tumor core and regressed multidrug resistant tumors.Structure and function of efflux pumps that confer resistance to drugsIdentifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene.Selective permeabilization of cervical cancer cells to an ionic DNA-binding cytotoxin by activation of P2Y receptors.Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21α-Methylmelianodiol in Lung Cancer CellsDifferential tissue accumulation of 2,3,7,8-Tetrachlorinated dibenzo-p-dioxin in Arabidopsis thaliana affects plant chronology, lipid metabolism and seed yield.Biodegradable cationic polymeric nanocapsules for overcoming multidrug resistance and enabling drug-gene co-delivery to cancer cells.Verapamil inhibits tumor progression of chemotherapy-resistant pancreatic cancer side population cells.Use of ribozymes and antisense oligodeoxynucleotides to investigate mechanisms of drug resistanceATP-binding cassette transporters in reproduction: a new frontier.Organometallic Iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis.Ursolic acid sensitized colon cancer cells to chemotherapy under hypoxia by inhibiting MDR1 through HIF-1α.Recent perspectives in ocular drug delivery.Molecular analysis of the multidrug transporter, P-glycoprotein.Influence of multidrug resistance and drug transport proteins on chemotherapy drug metabolism.Decursin in Angelica gigas Nakai (AGN) Enhances Doxorubicin Chemosensitivity in NCI/ADR-RES Ovarian Cancer Cells via Inhibition of P-glycoprotein Expression.GF120918, a P-glycoprotein modulator, increases the concentration of unbound amprenavir in the central nervous system in rats.Ruthenium(III) complexes of macrocyclic tertiary amines mediated NO release from s-nitrosothiols under in vitro and in vivo conditions.Protein kinases and multidrug resistance.3,5-Dibenzoyl-4-(3-phenoxyphenyl)-1,4-dihydro-2,6-dimethylpyridine (DP7) as a new multidrug resistance reverting agent devoid of effects on vascular smooth muscle contractility.Multidrug-resistant MCF-7 breast cancer cells contain deficient intracellular calcium pools.
P2860
Q24799793-53C44B08-22D9-45B2-8F55-34A1450E739BQ25256954-5414EAD4-1DDE-4A0E-AC4E-B8BDE8D28F3EQ26741846-3C3BC862-A00D-4A6C-9B05-DAB32993F542Q26776113-8EDEACD7-01F4-44F5-80CF-FDC4FE45FA42Q27330209-C5C9DC0F-0CE6-4020-8884-72C3A1BE319DQ28379120-7DEB4E9A-EA1E-4FFE-A3F4-23F730E44860Q28390477-63777D59-023E-42A7-8DB9-ED2D61F4AB31Q28576207-F3B9C901-F232-44B7-A4EA-4B8E7B65C447Q33197068-C113C863-24BC-4106-999E-627A1BAD9296Q33385367-6C61F582-8A11-4D02-8C4E-352FF46800CEQ33757055-863FE522-FA1F-4E2E-BA5D-82E284A93336Q34014475-986A7C34-7D31-44D9-A7EA-04D5B9E8EFA1Q34083438-AD47787C-7592-49EA-B4D1-982D2680F6A2Q34171201-304A9F10-9C8F-4FB0-8C43-F12AE4644D8CQ34557586-B11E55B2-3DD2-4292-9A02-9ACD5C039654Q34711648-6F507262-D325-42D9-86CF-5606C00677FFQ34994901-106B3E12-8A79-4130-9E12-7CE47D06849CQ35096900-4057E518-718F-4AEB-A66B-CCA54D5A2A66Q35146378-436D2CD8-7CA8-4672-A030-17C832E2DEB9Q35232504-0E5ECA66-2088-41C3-859B-84153DB00818Q35294152-93577923-9F9C-4EB3-8382-B4ADAE427F78Q35574195-4D89CFF5-92D9-4D75-9CA6-CA3C226D34D2Q35621198-8711903B-0D26-474F-AE9C-9208E6757262Q35670917-B6E085B8-E07F-4F82-8732-6875EF83B057Q35742037-E770FB1B-B7B8-435B-A000-D6B18572CB44Q35908348-EA7ED948-F0FA-4064-A964-4A7F87C2250BQ36017448-7C189C9E-32C3-424C-BB9F-4C4FB7AFF549Q36254793-FC44852B-E93B-472A-8913-B6CE7851FAD3Q36585155-CA1D4154-B0C9-4BC5-897D-CAD187CD5872Q36952837-CF4D17A7-D612-4709-96EE-265E0687BA1DQ37247157-5237DB04-2833-40D4-8229-69F46EA328ABQ37256549-A62A35FE-4D57-4DCE-A16F-F4230E6D7648Q37323494-FBD864AA-AA94-46E7-B8A1-A90800EAC2D3Q38402177-44FF1A74-F074-4677-9B55-ABE5F0DF295BQ38410843-E29425DF-767D-490E-9041-4AEF786BF429Q39652207-0EB255BD-0AF5-45FD-AA28-9165169DCB78Q39673971-99846489-3459-4330-8656-BD906951158BQ39918566-41D4F96F-3847-4A3E-9E96-CDD146807D2FQ40600268-DF263AC6-8C67-41A1-AC38-A4303A33D898Q40733010-E2C8DE87-68B7-4D30-9838-F3A784931E7A
P2860
description
1996 nî lūn-bûn
@nan
1996 թուականին հրատարակուած գիտական յօդուած
@hyw
1996 թվականին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
P-glycoproteins and multidrug resistance
@ast
P-glycoproteins and multidrug resistance
@en
P-glycoproteins and multidrug resistance
@nl
type
label
P-glycoproteins and multidrug resistance
@ast
P-glycoproteins and multidrug resistance
@en
P-glycoproteins and multidrug resistance
@nl
prefLabel
P-glycoproteins and multidrug resistance
@ast
P-glycoproteins and multidrug resistance
@en
P-glycoproteins and multidrug resistance
@nl
P3181
P1476
P-glycoproteins and multidrug resistance
@en
P2093
W T Bellamy
P304
P3181
P356
10.1146/ANNUREV.PA.36.040196.001113
P407
P577
1996-01-01T00:00:00Z